With ponatinib (Iclusig) receiving an accelerated approval from the FDA earlier this year for the treatment of Philadelphia ...

A study reveals semaglutide may alleviate knee osteoarthritis pain in obese patients, highlighting its potential beyond ...

Mean duration of Crohn's disease was 7.4 years. Nearly half (48.5%) had previous biologic therapy failure, 45.7% had previous ...

If you've never heard of fox nuts, you'd be forgiven for assuming that they don't sound particularly palatable. But they're ...

While tapering corticosteroids can reduce infections and hospitalizations for patients with severe alcohol-associated ...

Campus Chemical Instrument Center, Mass Spectrometry & Proteomics Facility, The Ohio State University, Columbus, USA ...

Acadia is on track to achieve over $1 billion in annualized sales in 2025. The next phase of growth could come from two ...

Though rare, some conditions like hypothyroidism, polycystic ovary syndrome (PCOS), or hormonal imbalances, can make weight ...

Zinc may help shorten the length and severity of a cold—and some even think it can prevent them. Experts weigh in and dispel ...

Poseida Therapeutics Inc. is being bought out for $1.5 billion by partner Roche Holdings Inc. to allogeneic CAR T therapies to treat hematologic malignancies. The two companies began their ...